![](/images/general/no_picture/200_user.png)
Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7744254
[patent_doc_number] => 20120021982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/185737
[patent_app_country] => US
[patent_app_date] => 2011-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20127
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021982.pdf
[firstpage_image] =>[orig_patent_app_number] => 13185737
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/185737 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION | Jul 18, 2011 | Abandoned |
Array
(
[id] => 7662177
[patent_doc_number] => 20110311446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (CMET) AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/182895
[patent_app_country] => US
[patent_app_date] => 2011-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 46060
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20110311446.pdf
[firstpage_image] =>[orig_patent_app_number] => 13182895
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/182895 | Peptides that specifically bind HGF receptor (cMet) and uses thereof | Jul 13, 2011 | Issued |
Array
(
[id] => 8664407
[patent_doc_number] => 08377868
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-19
[patent_title] => 'Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin'
[patent_app_type] => utility
[patent_app_number] => 13/180291
[patent_app_country] => US
[patent_app_date] => 2011-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12607
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13180291
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/180291 | Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin | Jul 10, 2011 | Issued |
Array
(
[id] => 10857218
[patent_doc_number] => 08883413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Compstatin analogs with improved activity'
[patent_app_type] => utility
[patent_app_number] => 13/177140
[patent_app_country] => US
[patent_app_date] => 2011-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 5752
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13177140
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/177140 | Compstatin analogs with improved activity | Jul 5, 2011 | Issued |
Array
(
[id] => 10831325
[patent_doc_number] => 08859494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament'
[patent_app_type] => utility
[patent_app_number] => 13/176333
[patent_app_country] => US
[patent_app_date] => 2011-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20905
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13176333
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/176333 | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament | Jul 4, 2011 | Issued |
Array
(
[id] => 10851208
[patent_doc_number] => 08877891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-04
[patent_title] => 'Method of producing a novel opioid peptide'
[patent_app_type] => utility
[patent_app_number] => 13/174262
[patent_app_country] => US
[patent_app_date] => 2011-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3251
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13174262
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/174262 | Method of producing a novel opioid peptide | Jun 29, 2011 | Issued |
Array
(
[id] => 7586323
[patent_doc_number] => 20110280833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'PEPTIDES, DERIVATIVES AND ANALOGS THEREOF, AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/168461
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 26667
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20110280833.pdf
[firstpage_image] =>[orig_patent_app_number] => 13168461
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168461 | Peptides, derivatives and analogs thereof, and methods of using same | Jun 23, 2011 | Issued |
Array
(
[id] => 8347099
[patent_doc_number] => 20120208023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'BIOACTIVATION OF PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/168399
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9231
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168399
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168399 | BIOACTIVATION OF PARTICLES | Jun 23, 2011 | Abandoned |
Array
(
[id] => 8375304
[patent_doc_number] => 08258096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Therapy procedure for drug delivery for trigeminal pain'
[patent_app_type] => utility
[patent_app_number] => 13/165646
[patent_app_country] => US
[patent_app_date] => 2011-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 18
[patent_no_of_words] => 19548
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13165646
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/165646 | Therapy procedure for drug delivery for trigeminal pain | Jun 20, 2011 | Issued |
Array
(
[id] => 9995886
[patent_doc_number] => 09040482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-26
[patent_title] => 'Octapeptide compounds and therapeutic use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/806510
[patent_app_country] => US
[patent_app_date] => 2011-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9092
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806510
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/806510 | Octapeptide compounds and therapeutic use thereof | Jun 20, 2011 | Issued |
Array
(
[id] => 7670064
[patent_doc_number] => 20110319333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/162010
[patent_app_country] => US
[patent_app_date] => 2011-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7889
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162010
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/162010 | Method and compositions for the treatment and detection of endothelin-1 related kidney diseases | Jun 15, 2011 | Issued |
Array
(
[id] => 7487433
[patent_doc_number] => 20110251120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'Antimicrobial Peptides and Methods of Identifying the Same'
[patent_app_type] => utility
[patent_app_number] => 13/161926
[patent_app_country] => US
[patent_app_date] => 2011-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20780
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251120.pdf
[firstpage_image] =>[orig_patent_app_number] => 13161926
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/161926 | Antimicrobial Peptides and Methods of Identifying the Same | Jun 15, 2011 | Abandoned |
Array
(
[id] => 7566932
[patent_doc_number] => 20110286995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'Drug Therapy for Celiac Sprue'
[patent_app_type] => utility
[patent_app_number] => 13/158916
[patent_app_country] => US
[patent_app_date] => 2011-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10111
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20110286995.pdf
[firstpage_image] =>[orig_patent_app_number] => 13158916
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/158916 | Drug Therapy for Celiac Sprue | Jun 12, 2011 | Abandoned |
Array
(
[id] => 8842221
[patent_doc_number] => 20130137849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'DIPEPTIDE LINKED MEDICINAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/697050
[patent_app_country] => US
[patent_app_date] => 2011-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71537
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697050
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/697050 | DIPEPTIDE LINKED MEDICINAL AGENTS | Jun 8, 2011 | Abandoned |
Array
(
[id] => 9295247
[patent_doc_number] => 20140038881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'Therapeutic Peptides'
[patent_app_type] => utility
[patent_app_number] => 13/984523
[patent_app_country] => US
[patent_app_date] => 2011-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 64542
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984523
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/984523 | Therapeutic peptides | Jun 7, 2011 | Issued |
Array
(
[id] => 7567973
[patent_doc_number] => 20110288036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'Methods for Treating or Preventing Vascular Graft Failure'
[patent_app_type] => utility
[patent_app_number] => 13/114872
[patent_app_country] => US
[patent_app_date] => 2011-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 37647
[patent_no_of_claims] => 119
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288036.pdf
[firstpage_image] =>[orig_patent_app_number] => 13114872
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/114872 | Methods for Treating or Preventing Vascular Graft Failure | May 23, 2011 | Abandoned |
Array
(
[id] => 7651812
[patent_doc_number] => 20110301081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'LONG-ACTING FORMULATIONS OF INSULINS'
[patent_app_type] => utility
[patent_app_number] => 13/110568
[patent_app_country] => US
[patent_app_date] => 2011-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 30309
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301081.pdf
[firstpage_image] =>[orig_patent_app_number] => 13110568
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/110568 | LONG-ACTING FORMULATIONS OF INSULINS | May 17, 2011 | Abandoned |
Array
(
[id] => 8077713
[patent_doc_number] => RE043298
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2012-04-03
[patent_title] => 'Peptides as NS3-serine protease inhibitors of hepatitis C virus'
[patent_app_type] => reissue
[patent_app_number] => 13/068159
[patent_app_country] => US
[patent_app_date] => 2011-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37395
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/043/RE043298.pdf
[firstpage_image] =>[orig_patent_app_number] => 13068159
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/068159 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Apr 21, 2011 | Issued |
Array
(
[id] => 7499551
[patent_doc_number] => 20110262492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'CATALYST AND BYPRODUCT-FREE NATIVE CHEMICAL LIGATION USING CYCLIC THIOESTER PRECURSORS'
[patent_app_type] => utility
[patent_app_number] => 13/090416
[patent_app_country] => US
[patent_app_date] => 2011-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7139
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262492.pdf
[firstpage_image] =>[orig_patent_app_number] => 13090416
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/090416 | Catalyst and byproduct-free native chemical ligation using cyclic thioester precursors | Apr 19, 2011 | Issued |
Array
(
[id] => 7720790
[patent_doc_number] => 20120010125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'Methods, compounds and pharmaceutical compositions for treating anxiety and mood disorders'
[patent_app_type] => utility
[patent_app_number] => 13/066620
[patent_app_country] => US
[patent_app_date] => 2011-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 37688
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010125.pdf
[firstpage_image] =>[orig_patent_app_number] => 13066620
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/066620 | Methods compounds and pharmaceutical compositions for treating anxiety and mood disorders | Apr 18, 2011 | Issued |